<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>DONNATAL- phenobarbital, hyoscyamine sulfate, atropine sulfate and scopolamine hydrobromideÂ tabletÂ </strong><br>Carilion Materials Management<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Donnatal Tablets</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
<h1></h1>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="L4a0adaea-e477-4640-9483-203d60a8b186"></a><a name="section-1"></a><p></p>
<h1>Description</h1>
<p class="First">Each DonnatalÂ® Tablet contains:</p>
<p>Phenobarbital, USP....................................... 16.2 mg</p>
<p>Hyoscyamine Sulfate, USP...................... 0.1037 mg</p>
<p>Atropine Sulfate, USP ...............................0.0194 mg</p>
<p>Scopolamine Hydrobromide, USP ...........0.0065 mg</p>
<p></p>
<p>INACTIVE INGREDIENTS: Anhydrous Lactose, Calcium Stearate, Colloidal</p>
<p>Silicon Dioxide, Corn Starch, and Microcrystalline Cellulose.</p>
</div>
<div class="Section" data-sectionCode="51727-6">
<a name="L0c3c43ab-e2d8-4053-84af-b779a0895be5"></a><a name="section-2"></a><p></p>
<h1>INACTIVE INGREDIENTS</h1>
<p class="First">Anhydrous Lactose, Calcium Stearate, Colloidal Silicon Dioxide, Corn Starch, and Microcrystalline Cellulose</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="L195f1311-e415-4268-8ff5-1a23898893f5"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">This drug combination provides natural belladonna alkaloids in a specific, fixed ratio combined with phenobarbital to</p>
<p>provide peripheral anticholinergic/antispasmodic action and mild sedation.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="L51b0fcad-c354-4bf2-a067-d51b4c94557f"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Based on a review of this drug by the National Academy of Sciences-National Research Council and/or other</p>
<p>information, FDA has classified the following indications as â€œpossiblyâ€? effective:</p>
<p>For use as adjunctive therapy in the treatment of <span class="product-label-link" type="condition" conceptid="75576" conceptname="Irritable bowel syndrome">irritable bowel syndrome</span> (<span class="product-label-link" type="condition" conceptid="75576" conceptname="Irritable bowel syndrome">irritable colon</span>, <span class="product-label-link" type="condition" conceptid="75576" conceptname="Irritable bowel syndrome">spastic colon</span>, <span class="product-label-link" type="condition" conceptid="75576" conceptname="Irritable bowel syndrome">mucous colitis</span>)</p>
<p>and acute <span class="product-label-link" type="condition" conceptid="4184503" conceptname="Enterocolitis">enterocolitis</span>.</p>
<p>May also be useful as adjunctive therapy in the treatment of <span class="product-label-link" type="condition" conceptid="4057053" conceptname="Acute duodenal ulcer">duodenal ulcer</span>. IT HAS NOT BEEN SHOWN</p>
<p>CONCLUSIVELY WHETHER ANTICHOLINERGIC/ANTISPASMODIC DRUGS AID IN THE HEALING OF A</p>
<p><span class="product-label-link" type="condition" conceptid="4057053" conceptname="Acute duodenal ulcer">DUODENAL ULCER</span>, DECREASE THE RATE OF RECURRENCES OR PREVENT COMPLICATIONS.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="L8a7f3331-6e9c-45ff-8325-716037c12cd5"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">Glaucoma</span>, <span class="product-label-link" type="condition" conceptid="194406" conceptname="Urinary tract obstruction">obstructive uropathy</span> (for example, <span class="product-label-link" type="condition" conceptid="433813" conceptname="Bladder neck obstruction">bladder neck obstruction</span> due to <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>); obstructive</p>
<p>disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">paralytic ileus</span>, intestinal atony of</p>
<p>the elderly or debilitated patient; unstable cardiovascular status in acute <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span>; severe <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span></p>
<p>especially if complicated by toxic mega-colon; <span class="product-label-link" type="condition" conceptid="76685" conceptname="Myasthenia gravis">myasthenia gravis</span>; <span class="product-label-link" type="condition" conceptid="4224004" conceptname="Hiatal hernia">hiatal hernia</span> associated with <span class="product-label-link" type="condition" conceptid="30437" conceptname="Gastro-esophageal reflux disease with esophagitis">reflux esophagitis</span>.</p>
<p>DonnatalÂ® is contraindicated in patients with known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the ingredients. Phenobarbital is</p>
<p>contraindicated in <span class="product-label-link" type="condition" conceptid="4120604" conceptname="Acute intermittent porphyria">acute intermittent porphyria</span> and in those patients in whom phenobarbital produces <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span></p>
<p>and/or <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="La3c8dbb8-750f-4f63-9dd0-2e0e04567e2b"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">In the presence of a high environmental temperature, <span class="product-label-link" type="condition" conceptid="437744" conceptname="Heat exhaustion">heat prostration</span> can occur with belladonna alkaloids (<span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and</p>
<p>heatstroke due to decreased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>).</p>
<p><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span> may be an early symptom of incomplete <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">intestinal obstruction</span>, especially in patients with ileostomy or</p>
<p>colostomy. In this instance, treatment with this drug would be inappropriate and possibly harmful.</p>
<p>DonnatalÂ® may produce <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>. The patient should be warned, should these occur, not to</p>
<p>engage in activities requiring mental alertness, such as operating a motor vehicle or other machinery, and not to</p>
<p>perform hazardous work.</p>
<p>Phenobarbital may decrease the effect of anticoagulants, and necessitate larger doses of the anticoagulant for optimal</p>
<p>effect. When the phenobarbital is discontinued, the dose of the anticoagulant may have to be decreased.</p>
<p>Phenobarbital may be habit forming and should not be administered to individuals known to be addiction prone or to</p>
<p>those with a history of physical and/or psychological <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> upon drugs.</p>
<p>Since barbiturates are metabolized in the liver, they should be used with caution and initial doses should be small in</p>
<p>patients with hepatic dysfunction.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="Lb017a1b5-cfd4-415b-bf76-fc6e14b6b768"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Use with caution in patients with: <span class="product-label-link" type="condition" conceptid="4080146" conceptname="Autonomic neuropathy">autonomic neuropathy</span>, hepatic or <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, coronary heart</p>
<p>disease, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, and <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>.</p>
<p>Belladonna alkaloids may produce a delay in gastric emptying (antral stasis) which would complicate the management</p>
<p>of <span class="product-label-link" type="condition" conceptid="4265600" conceptname="Gastric ulcer">gastric ulcer</span>.</p>
<p>Do not rely on the use of the drug in the presence of complication of <span class="product-label-link" type="condition" conceptid="197917" conceptname="Disorder of biliary tract">biliary tract disease</span>.</p>
<p>Theoretically, with overdosage, a curare-like action may occur.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="Lfb30b094-bdd3-4cf5-85d1-72d3753f70a3"></a><a name="section-8"></a><p></p>
<h1>CARCINOGENESIS, MUTAGENESIS,
  IMPAIRMENT OF FERTILITY</h1>
<p class="First">Long-term studies in animals have not been performed to evaluate carcinogenic potential.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="La61c4d9b-da3e-45e0-93bd-0e51dd196dfd"></a><a name="section-9"></a><p></p>
<h1>PREGNANCY</h1>
<p class="First">PREGNANCY CATEGORY C</p>
<p>Animal reproduction studies have not been conducted with DonnatalÂ®. It is not known whether DonnatalÂ® can cause</p>
<p>fetal harm when administered to a pregnant woman or can affect reproduction capacity. DonnatalÂ® should be given to</p>
<p>a pregnant woman only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="L2144e663-72d3-4472-ad9a-efdf69780dc8"></a><a name="section-10"></a><p></p>
<h1>NURSING MOTHERS</h1>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution</p>
<p>should be exercised when DonnatalÂ® is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="L808816e8-3cb8-4595-a0ee-500b4fb25440"></a><a name="section-11"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Adverse reactions may include <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">xerostomia</span>; <span class="product-label-link" type="condition" conceptid="201688" conceptname="Delay when starting to pass urine">urinary hesitancy</span> and retention; <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>; <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>; <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span>;</p>
<p><span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span>; <span class="product-label-link" type="condition" conceptid="375263" conceptname="Cycloplegia">cycloplegia</span>; increased ocular <span class="product-label-link" type="condition" conceptid="4200706" conceptname="Tension">tension</span>; <span class="product-label-link" type="condition" conceptid="4289517" conceptname="Loss of taste">loss of taste</span> sense; <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>; <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>; <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>; <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>;</p>
<p><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>; <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>; <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>; <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>; <span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">impotence</span>; suppression of lactation; <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>; <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">bloated feeling</span>;</p>
<p><span class="product-label-link" type="condition" conceptid="4150129" conceptname="Musculoskeletal pain">musculoskeletal pain</span>; severe <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span> or drug idiosyncrasies, including <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> and other dermal</p>
<p>manifestations; and decreased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>. Acquired <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to barbituates consists chiefly in <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span></p>
<p>that occur especially in persons who tend to have <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, angiodema and similar conditions. <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span></p>
<p>reactions in this category include localized <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>, particularly of the eyelids, cheeks, or lips, and erythematous</p>
<p><span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span>. Rarely, <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span> (e.g. <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span> and <span class="product-label-link" type="condition" conceptid="443754" conceptname="Lyell's toxic epidermal necrolysis, subepidermal type">toxic epidermal necrolysis</span>) may be</p>
<p>caused by phenobarbital and can prove fatal. The <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin eruption</span> may be associated with <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="373995" conceptname="Delirium">delirium</span>, and marked</p>
<p>degenerative changes in the liver and other parenchymatous organs. In a few cases, <span class="product-label-link" type="condition" conceptid="435789" conceptname="Megaloblastic anemia">megaloblastic anemia</span> has been</p>
<p>associated with the chronic use of phenobarbital. Elderly patients may react with symptoms of <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>,</p>
<p><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, and other untoward manifestations to even small doses of the drug. Phenobarbital may produce</p>
<p><span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span> in some patients, rather than a sedative effect. In patients habituated to barbiturates, abrupt withdrawal</p>
<p>may produce <span class="product-label-link" type="condition" conceptid="373995" conceptname="Delirium">delirium</span> or <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="L164d60fe-4ab0-4e8f-ad53-e9c43ffb3bd8"></a><a name="section-12"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The dosage of DonnatalÂ® should be adjusted to the needs of the dividual patient to assure symptomatic control with a</p>
<p>minimum of adverse effects.</p>
<p>DonnatalÂ® Tablets. Adults: One or two DonnatalÂ® tablets three or four times a day according to condition and severity</p>
<p>of symptoms.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="L0f84b203-21fa-4a6f-b160-82f49019be77"></a><a name="section-13"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">The signs and symptoms of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> are <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">dilated pupils</span>, hot and <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">dry skin</span>,</p>
<p><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, dryness of the mouth, difficulty in swallowing, and CNS stimulation. Treatment should consist of gastric</p>
<p>lavage, emetics, and activated charcoal. If indicated, parenteral cholinergic agents such as physostigmine or</p>
<p>bethanechol chloride, should be used.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="L787b8916-ae3a-4b29-88a7-9380361950a0"></a><a name="section-14"></a><p></p>
<h1>How Supplied</h1>
<p class="First">NDC:68151-0607-1 in a PACKAGE of 1 TABLETS</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="L7bdfccdb-b2e6-4f47-bf85-f627d1089d2b"></a><a name="section-15"></a><p></p>
<h1>Belladonna Alkabids/Phenorbarb TAB</h1>
<div class="Figure"><img alt="Label Image" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7343cfab-9bd9-4dcb-bbef-9592ffd5d7e6&amp;name=68151-0607.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DONNATALÂ 		
					</strong><br><span class="contentTableReg">phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:68151-0607(NDC:66213-425)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>PHENOBARBITAL</strong> (PHENOBARBITAL) </td>
<td class="formItem">PHENOBARBITAL</td>
<td class="formItem">16.2Â mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>HYOSCYAMINE SULFATE</strong> (HYOSCYAMINE) </td>
<td class="formItem">HYOSCYAMINE SULFATE</td>
<td class="formItem">0.1037Â mg</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ATROPINE SULFATE</strong> (ATROPINE) </td>
<td class="formItem">ATROPINE SULFATE</td>
<td class="formItem">0.0194Â mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SCOPOLAMINE HYDROBROMIDE</strong> (SCOPOLAMINE) </td>
<td class="formItem">SCOPOLAMINE HYDROBROMIDE</td>
<td class="formItem">0.0065Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ANHYDROUS LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CALCIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SILICON DIOXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">white</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">SEMI-CIRCLE</td>
<td class="formLabel">Size</td>
<td class="formItem">8mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">D;Donnatal</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:68151-0607-1</td>
<td class="formItem">1  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">05/07/2008</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Carilion Materials Management
							(079239644)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>Carilion Materials Management (079239644)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Carilion Materials Management</td>
<td class="formItem"></td>
<td class="formItem">079239644</td>
<td class="formItem">REPACK(68151-0607)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>edc24a6c-4754-4695-af73-de2797457ba7</div>
<div>Set id: 7343cfab-9bd9-4dcb-bbef-9592ffd5d7e6</div>
<div>Version: 2</div>
<div>Effective Time: 20131203</div>
</div>
</div>Â <div class="DistributorName">Carilion Materials Management</div></p>
</body></html>
